VAPO vs. INBS, VVOS, PSTV, NURO, AVGR, VERO, AFIB, TMDIF, STSS, and IONM
Should you be buying Vapotherm stock or one of its competitors? The main competitors of Vapotherm include Intelligent Bio Solutions (INBS), Vivos Therapeutics (VVOS), Plus Therapeutics (PSTV), NeuroMetrix (NURO), Avinger (AVGR), Venus Concept (VERO), Acutus Medical (AFIB), Titan Medical (TMDIF), Sharps Technology (STSS), and Assure (IONM). These companies are all part of the "surgical & medical instruments" industry.
Vapotherm (NYSE:VAPO) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations.
Vapotherm has a net margin of -84.74% compared to Intelligent Bio Solutions' net margin of -544.63%. Vapotherm's return on equity of 0.00% beat Intelligent Bio Solutions' return on equity.
43.1% of Vapotherm shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 15.8% of Vapotherm shares are held by company insiders. Comparatively, 0.3% of Intelligent Bio Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Vapotherm received 88 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users.
Intelligent Bio Solutions has lower revenue, but higher earnings than Vapotherm. Vapotherm is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
In the previous week, Vapotherm's average media sentiment score of 0.00 equaled Intelligent Bio Solutions'average media sentiment score.
Vapotherm has a beta of -1.11, indicating that its stock price is 211% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.83, indicating that its stock price is 383% more volatile than the S&P 500.
Summary
Vapotherm beats Intelligent Bio Solutions on 8 of the 12 factors compared between the two stocks.
Get Vapotherm News Delivered to You Automatically
Sign up to receive the latest news and ratings for VAPO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VAPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vapotherm Competitors List
Related Companies and Tools
